VanEck Pharmaceutical ETF (PPH)
NASDAQ: PPH
· Real-Time Price · USD
88.35
0.39 (0.44%)
At close: Jul 01, 2025, 3:59 PM
89.39
1.18%
After-hours: Jul 01, 2025, 06:14 PM EDT
0.44% (1D)
| Bid | 88.16 |
| Market Cap | 1.02B |
| AUM | 612.06M |
| NAV | 87.59 |
| EPS (ttm) | 3.81 |
| PE Ratio (ttm) | 23.22 |
| Shares Out | 11.55M |
| Inception Date | Dec 19, 2011 |
| Ask | 89.39 |
| Volume | 717.83K |
| Open | 87.14 |
| Previous Close | 87.96 |
| Day's Range | 87.14 - 89.20 |
| 52-Week Range | 77.67 - 99.51 |
| Holdings | 25 |
| Expense Ratio | 0.36% |
About PPH
The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The index includes common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.
Asset Class Equity
Ticker Symbol PPH
Inception Date Dec 19, 2011
Provider Vaneck
Website Fund Home Page
Exchange NASDAQ
Top 10 Holdings 72.31% of assets
| Name | Symbol | Weight |
|---|---|---|
| Eli Lilly And Compan... | LLY | 18.56% |
| Johnson & Johnson | JNJ | 10.03% |
| Novartis Ag | NVS | 7.62% |
| Novo Nordisk A/s | NVO | 7.56% |
| Merck & Co., Inc. | MRK | 5.85% |
| Mckesson Corporation | MCK | 4.73% |
| Pfizer Inc. | PFE | 4.58% |
| Sanofi | SNY | 4.50% |
| Abbvie Inc. | ABBV | 4.49% |
| Astrazeneca PLC | AZN | 4.39% |
Dividends Dividend Yield 1.92%
| Ex-Dividend | Amount | Payment Date |
|---|---|---|
| Apr 1, 2025 | $0.5245 | Apr 4, 2025 |
| Dec 27, 2024 | $0.4110 | Dec 30, 2024 |
| Oct 1, 2024 | $0.4090 | Oct 4, 2024 |
| Jul 1, 2024 | $0.3558 | Jul 5, 2024 |
| Apr 1, 2024 | $0.5328 | Apr 5, 2024 |
